How Pfizer successfully leveraged analytics and AI to scale their initiatives | VB Transform 2020
How Pfizer successfully leveraged analytics and AI to scale their initiatives and achieve results
Pfizer has successfully created a culture of collaboration and co-creation around analytics and AI that has allowed them to significantly scale their initiatives and achieve results. By taking a broadly inclusive view on who should contribute to those processes, they've un-siloed their teams, and provided them with means to use the most advanced techniques on the largest datasets. In this fireside chat, Chris Kakkanatt, Senior Director of Data Science at Pfizer speaks with Kurt Muehmel, Chief Customer Officer at Dataiku, about the decade-long journey that they have taken to achieve this human-centric, AI-driven transformation and walks the audience through the business, technology and organizational lessons learnt and best practices that they can implement in their businesses.
Chris Kakkanat, Data Science Senior Director/Team Leader, Pfizer
In conversation with Kurt Muehmel, CCO, Dataiku